No abstract available
Keywords:
amyotrophic lateral sclerosis; biomarkers; frontotemporal dementia; precision medicine; risk factor.
Grants and funding
The study was supported by the AGING Project for Department of Excellence at the Department of Translational Medicine (DIMET), Università del Piemonte Orientale, Novara, Italy.